<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0005">
 <label>Table 1</label>
 <caption>
  <p>Impacts of CCR5Δ32 on West Nile virus (WNV) infection.</p>
 </caption>
 <alt-text id="at0085">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Population</th>
    <th align="left">Sample</th>
    <th align="left">Main findings</th>
    <th align="left">References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">American</td>
    <td align="left">395 symptomatic WNV + individuals; 145 symptomatic but non-infected individuals; 1318 controls (blood donors)</td>
    <td align="left">The CCR5Δ32 homozygous genotype was strongly associated with increased risk of symptomatic WNV infection</td>
    <td align="left">
     <xref rid="bib0540" ref-type="bibr">Glass et al. (2006)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">American</td>
    <td align="left">224 symptomatic WNV + individuals; 1318 controls (blood donors)</td>
    <td align="left">Corroborating data from 
     <xref rid="bib0540" ref-type="bibr">Glass et al. (2006)</xref>, the CCR5Δ32 homozygous genotype was strongly associated with increased risk of symptomatic WNV infection
    </td>
    <td align="left">
     <xref rid="bib0905" ref-type="bibr">Lim et al. (2008)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">American</td>
    <td align="left">634 WNV + individuals; 422 non-infected individuals</td>
    <td align="left">CCR5Δ32 homozygous genotype was associated with clinical symptoms of WNV infection; No association between CCR5Δ32 and susceptibility to WNV infection</td>
    <td align="left">
     <xref rid="bib0910" ref-type="bibr">Lim et al. (2010)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">American, Canadian</td>
    <td align="left">385 symptomatic WNV + individuals; 328 asymptomatic WNV + individuals; 1318 controls [blood donors from 
     <xref rid="bib0540" ref-type="bibr">Glass et al. (2006)</xref>]
    </td>
    <td align="left">No association of CCR5Δ32 and WNV infection considering symptomatic and asymptomatic WNV + individuals; Considering a dominant model of inheritance of CCR5Δ32 and using controls from 
     <xref rid="bib0540" ref-type="bibr">Glass et al. (2006)</xref>, the CCR5Δ32 was associated with symptomatic WNV infection and infection risk
    </td>
    <td align="left">
     <xref rid="bib0125" ref-type="bibr">Bigham et al. (2011)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">American, Canadian</td>
    <td align="left">821 WNV + individuals with severe infection; 1233 individuals with non-severe infection</td>
    <td align="left">No association between CCR5Δ32 and WNV infection severity</td>
    <td align="left">
     <xref rid="bib0940" ref-type="bibr">Loeb et al. (2011)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Israeli (Ashkenazi Jews)</td>
    <td align="left">39 symptomatic WNV + individuals; 61 non-infected individuals</td>
    <td align="left">No association between CCR5Δ32 and WNV infection</td>
    <td align="left">
     <xref rid="bib0315" ref-type="bibr">Danial-Farran et al. (2015)</xref>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
